Literature DB >> 20376303

Genetic and Chemical Models of Colorectal Cancer in Mice.

Mandayam O Nandan1, Vincent W Yang.   

Abstract

Colorectal cancer (CRC) is a significant health concern because of its associated mortality. Most CRCs exhibit dysregulation of the Wnt signaling pathway, caused by mutational inactivation of the adenomatous polyposis coli tumor suppressor gene (APC) or mutational activation of β-catenin. Disease progression is accompanied by additional mutations in the KRAS oncogene and p53 tumor suppressor gene. Other CRCs are microsatellite unstable because of mutational inactivation or epigenetic silencing of key molecules responsible for DNA mismatch repair. This review focuses on several common mouse models of CRC, highlighting the consequences of germline mutation of the aforementioned tumor suppressor genes or proto-oncogenes. This article also discusses chemical carcinogens that adversely affect the intestinal tissues with formation of colorectal neoplasia in mice. These mouse models have significantly contributed to the understanding of the mechanisms responsible for CRC pathogenesis and also may serve as potential vehicles for therapeutic intervention.

Entities:  

Year:  2010        PMID: 20376303      PMCID: PMC2850068          DOI: 10.1007/s11888-010-0046-1

Source DB:  PubMed          Journal:  Curr Colorectal Cancer Rep        ISSN: 1556-3790


  85 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  K-ras is essential for the development of the mouse embryo.

Authors:  K Koera; K Nakamura; K Nakao; J Miyoshi; K Toyoshima; T Hatta; H Otani; A Aiba; M Katsuki
Journal:  Oncogene       Date:  1997-09-04       Impact factor: 9.867

3.  Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis.

Authors:  Mei Dong; Kishore Guda; Prashant R Nambiar; Anahita Rezaie; Glenn S Belinsky; Gérard Lambeau; Charles Giardina; Daniel W Rosenberg
Journal:  Carcinogenesis       Date:  2003-02       Impact factor: 4.944

4.  Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model.

Authors:  Isao Okayasu; Masahiro Yamada; Tetuo Mikami; Tsutomu Yoshida; Jun Kanno; Toshifumi Ohkusa
Journal:  J Gastroenterol Hepatol       Date:  2002-10       Impact factor: 4.029

5.  Interleukin-10-deficient mice develop chronic enterocolitis.

Authors:  R Kühn; J Löhler; D Rennick; K Rajewsky; W Müller
Journal:  Cell       Date:  1993-10-22       Impact factor: 41.582

6.  An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.

Authors:  Melanie H Kucherlapati; Kyeryoung Lee; Andrew A Nguyen; Alan B Clark; Harry Hou; Andrew Rosulek; Hua Li; Kan Yang; Kunhua Fan; Martin Lipkin; Roderick T Bronson; Linda Jelicks; Thomas A Kunkel; Raju Kucherlapati; Winfried Edelmann
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

7.  Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP).

Authors:  S Ichii; A Horii; S Nakatsuru; J Furuyama; J Utsunomiya; Y Nakamura
Journal:  Hum Mol Genet       Date:  1992-09       Impact factor: 6.150

8.  Deletion of TLR5 results in spontaneous colitis in mice.

Authors:  Matam Vijay-Kumar; Catherine J Sanders; Rebekah T Taylor; Amrita Kumar; Jesse D Aitken; Shanthi V Sitaraman; Andrew S Neish; Satoshi Uematsu; Shizuo Akira; Ifor R Williams; Andrew T Gewirtz
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

9.  TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway.

Authors:  Patty Trobridge; Sue Knoblaugh; M Kay Washington; Nina M Munoz; Karen D Tsuchiya; Andres Rojas; Xiaoling Song; Cornelia M Ulrich; Takehiko Sasazuki; Senji Shirasawa; William M Grady
Journal:  Gastroenterology       Date:  2009-02-04       Impact factor: 22.682

10.  Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation.

Authors:  A R Moser; A R Shoemaker; C S Connelly; L Clipson; K A Gould; C Luongo; W F Dove; P H Siggers; R L Gardner
Journal:  Dev Dyn       Date:  1995-08       Impact factor: 3.780

View more
  14 in total

1.  Mitochondrial DNA Integrity Is Maintained by APE1 in Carcinogen-Induced Colorectal Cancer.

Authors:  Joan Ballista-Hernández; Margaly Martínez-Ferrer; Roman Vélez; Consuelo Climent; Maria M Sánchez-Vázquez; Ceidy Torres; Adlin Rodríguez-Muñoz; Sylvette Ayala-Peña; Carlos A Torres-Ramos
Journal:  Mol Cancer Res       Date:  2017-03-30       Impact factor: 5.852

2.  An Update on the Biology of RAS/RAF Mutations in Colorectal Cancer.

Authors:  Mandayam O Nandan; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2011-06-01

3.  Hsp70 exerts oncogenic activity in the Apc mutant Min mouse model.

Authors:  Yun Tao; Jeannette S Messer; Kathleen H Goss; John Hart; Marc Bissonnette; Eugene B Chang
Journal:  Carcinogenesis       Date:  2016-05-04       Impact factor: 4.944

Review 4.  Mouse models for the discovery of colorectal cancer driver genes.

Authors:  Christopher R Clark; Timothy K Starr
Journal:  World J Gastroenterol       Date:  2016-01-14       Impact factor: 5.742

Review 5.  Persistence of DNA adducts, hypermutation and acquisition of cellular resistance to alkylating agents in glioblastoma.

Authors:  R J Head; M F Fay; L Cosgrove; K Y C Fung; D Rundle-Thiele; J H Martin
Journal:  Cancer Biol Ther       Date:  2017-11-20       Impact factor: 4.742

6.  Inactivation of the retinoblastoma gene yields a mouse model of malignant colorectal cancer.

Authors:  T Parisi; R T Bronson; J A Lees
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

7.  The effect of a germline mutation in the APC gene on β-catenin in human embryonic stem cells.

Authors:  Nofar Yedid; Yael Kalma; Mira Malcov; Ami Amit; Revital Kariv; Michal Caspi; Rina Rosin-Arbesfeld; Dalit Ben-Yosef
Journal:  BMC Cancer       Date:  2016-12-23       Impact factor: 4.430

8.  Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells.

Authors:  Robert A Adair; Karen J Scott; Sheila Fraser; Fiona Errington-Mais; Hardev Pandha; Matt Coffey; Peter Selby; Graham P Cook; Richard Vile; Kevin J Harrington; Giles Toogood; Alan A Melcher
Journal:  Int J Cancer       Date:  2012-11-26       Impact factor: 7.396

9.  Tumorigenic fragments of APC cause dominant defects in directional cell migration in multiple model systems.

Authors:  Scott A Nelson; Zhouyu Li; Ian P Newton; David Fraser; Rachel E Milne; David M A Martin; David Schiffmann; Xuesong Yang; Dirk Dormann; Cornelis J Weijer; Paul L Appleton; Inke S Näthke
Journal:  Dis Model Mech       Date:  2012-04-05       Impact factor: 5.758

10.  Characterization of hERG1 channel role in mouse colorectal carcinogenesis.

Authors:  Antonella Fiore; Laura Carraresi; Angela Morabito; Simone Polvani; Angelo Fortunato; Elena Lastraioli; Angelo P Femia; Emanuele De Lorenzo; Giovanna Caderni; Annarosa Arcangeli
Journal:  Cancer Med       Date:  2013-07-22       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.